Showing results (101-110 of 254) with videos related to
Sort By:
Pageof 26
BMC Infectious Diseases|July 18, 2009
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugsClaudia Alteri, Valentina Svicher, Caterina Gori, et al.The Journal of Antimicrobial Chemotherapy|November 27, 2018
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patientsCathia Soulie, Maria Mercedes Santoro, Charlotte Charpentier, et al.Journal of Global Antimicrobial Resistance|January 30, 2025
Assessing the utilization of HIV genotype resistance testing: Insight from Italian Infectious Diseases UnitsAndrea De Vito, Antonia Bezenchek, Rossana Scutari, et al.Systematic Reviews|April 27, 2020
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocolEzechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, Valantine Ngum Ndze, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2016
Occupational HIV Infection in a Research Laboratory With Unknown Mode of Transmission: A Case ReportAlessandro Soria, Claudia Alteri, Gabriella Scarlatti, et al.The Journal of Antimicrobial Chemotherapy|June 26, 2025
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona CohortRoberta Gagliardini, Sara De Benedittis, Alessandro Tavelli, et al.Journal of Hepatology|December 2, 2008
The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypesValentina Svicher, Caterina Gori, Maria Trignetti, et al.Journal of Virology|July 1, 2006
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitorsValentina Svicher, Tobias Sing, Maria Mercedes Santoro, et al.Frontiers in Immunology|June 6, 2022
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 MacrophagesFederica De Santis, Ana Borrajo Lopez, Sara Virtuoso, et al.Journal of Global Antimicrobial Resistance|August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyMaria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.Pageof 26